Captario

3 articles about Captario

• Captario Partners with Sobi to Assist Them with Strategic Drug Development Initiatives

  10/5/2022

  Captario is pleased to announce that Sobi®, one of the largest Swedish biopharmaceutical companies developing and providing sustainable access to innovative medicines for the treatment of rare diseases, has stepped ahead of their peers’ digital journey by choosing to partner with Captario in their efforts to increase efficiency in their strategic drug development initiatives.

• Captario Launches Professional Services to Further Enable Strategic Decision-Making

  3/9/2022

  Captario, the life science SaaS-platform decision analytics company, announces the launch of Professional Services to further enable strategic decision-making throughout the drug development process.

• Captario Has Been Selected by Alnylam Pharmaceuticals To Optimize Their Portfolio Management Process

  1/11/2022

  Captario, a Gothenburg-based life sciences decision analytics SaaS platform & services company, has been chosen by Alnylam Pharmaceuticals, a global biopharmaceutical company based in Cambridge, MA, to support their digital transformation journey of optimizing strategic project and portfolio forecasting and modeling. Focused on the discovery,